• Norfluoxetine, Urine
  • Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency, Genetic Mutation Analysis
  • Autoinflammatory Primary Immunodeficiency (PID) Gene Panel
  • Toxoplasma IgG
  • Splicing Factor 3b Subunit B1 (SF3B1) Gene Mutation Analysis
  • Phenobarbital, Urine
  • Hepatitis B & D virus coinfection
  • Vitamin K1
  • BRCA1 and BRCA2 Gene Mutations Analysis (duplication/deletion and large gene rearrangements)
  • Eosinophil Cationic Protein
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test

Methodology
Access to BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance is restricted.